Head-to-head · WeighScore
AVARA Rx vs Fitstry
The verdict
AVARA Rx takes it — 62.8/100 to 61.5/100, but only just.
AVARA Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AVARA Rx is a nationwide DTC telehealth platform offering compounded semaglutide and tirzepatide plus brand-name Wegovy, Zepbound, and Foundayo consultations, alongside HRT, TRT, and longevity add-ons. Fitstry is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AVARA Rx | Fitstry |
|---|---|---|
| WeighScore | 62.8/100 | 61.5/100 |
| Grade | C | C |
| Scorecard rank | #263 | #292 |
| Semaglutide | $229/mo (starting dose, compounded) | $179/mo (annual plan, plus a separate fee, compounded) |
| Tirzepatide | $279/mo (starting dose, compounded) | $269/mo (annual plan, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #263 · C
Strengths
- Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
- Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
- All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
- Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
- LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities
Where it loses points
- Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
- Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
- LegitScript certification number not shown — badge only, so no direct lookup
- No named medical director (Beluga Health is the network, not a named MD)
- Lab work requirements not specified, and consultation fee not broken out from medication cost
Graded #292 · C
Strengths
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
Where it loses points
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.